MyFinsight
Home
Blog
About
Marketable securities -
current
$182,814K
(25.01%↑ Y/Y)
Cash and cash
equivalents
$110,004K
(8.41%↑ Y/Y)
Prepaid expenses
$14,688K
(7.26%↑ Y/Y)
Accounts receivable
$7,179K
Other current assets
$6,313K
(-8.12%↓ Y/Y)
Interest receivable
$1,540K
(-5.06%↓ Y/Y)
Total current assets
$322,538K
(19.47%↑ Y/Y)
Marketable securities -
long-term
$61,502K
(-42.66%↓ Y/Y)
Property and equipment,
net
$4,829K
(44.45%↑ Y/Y)
Restricted cash - long-term
$3,227K
(347.57%↑ Y/Y)
Operating right-of-use
assets
$1,870K
(-41.89%↓ Y/Y)
Total assets
$393,966K
(2.46%↑ Y/Y)
Total liabilities and
stockholders equity
$393,966K
(2.46%↑ Y/Y)
Total stockholders
equity
$345,547K
(3.17%↑ Y/Y)
Total liabilities
$48,419K
(-2.31%↓ Y/Y)
Accumulated deficit
-$609,336K
(-51.79%↓ Y/Y)
Accumulated other
comprehensive (loss) income
-$542K
(-664.58%↓ Y/Y)
Additional paid-in capital
$955,419K
(29.76%↑ Y/Y)
Total current
liabilities
$41,930K
(8.41%↑ Y/Y)
Total long-term
liabilities
$6,489K
(-40.40%↓ Y/Y)
Common stock, par value
of 0.0001 per share...
$6K
(20.00%↑ Y/Y)
Accrued and other
current liabilities
$28,613K
(11.70%↑ Y/Y)
Deferred revenue -
current portion
$8,523K
(-2.58%↓ Y/Y)
Accounts payable
$4,794K
(11.15%↑ Y/Y)
Deferred revenue - net of
current portion
$5,652K
(-41.32%↓ Y/Y)
Other long-term
liabilities
$837K
(-33.31%↓ Y/Y)
Back
Back
Balance Sheet
Stoke Therapeutics, Inc. (STOK)
Stoke Therapeutics, Inc. (STOK)
source: myfinsight.com